Lupus Capital PLC
27 November 2002
27 November 2002
Lupus Capital plc
Indicative Offer for Gall Thomson Environmental Limited
The Board of Lupus Capital plc ('Lupus' or the 'Company') announces that
yesterday evening it received an indicative offer for its wholly owned
subsidiary Gall Thomson Environmental Limited ('Gall Thomson') of £14.5 million
payable in cash on completion for 100% of its issued share capital. This offer
is subject to contract and to full due diligence and is prior to deduction of
costs which will be associated with the offer and incurred by the Company. Such
an indicative offer represents a material increase on the level of offers
received for Gall Thomson by Lupus during the sale processes carried out during
the past two years.
- Ends -
Lupus Capital plc Tel: 020 7976 8000
Charles Ryder, Chief Executive www.lupuscapital.com
James Orr, Finance Director
Oriel Securities Limited Tel: 020 7710 7600
Simon Bragg/Adrian McMillan
Merlin Financial Tel: 020 7606 1244
Paul Downes/Tom Randell
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.